ultra high-risk - Globe Thesis

Keyword [ultra high-risk] Result: 1 - 20 \| Page: 1 of 2
1.	Study On Intervention Effect Of Cognitive Behavioral Therapy In Schizophrenia Patients With High Risk
2.	Exploration Of The Risk Factors And Assessment On The Clinical Staging Systems Of Patients With Multiple Myeloma
3.	Outcome Of Clinical High-risk Of Psychosis And Its Neuropsychological Mechanisms On Social Cognition Deficits
4.	Diffusion Tensor Imaging Study In White Matter Of Ultra-high-risk For Psychosis
5.	Comparative Analysis Of Gray Matter Volume Abnormalities Between First-episode,drug-na(?)ve Patients In Schizophrenia And Its Ultra High-risk Population
6.	Comparative Study Of Cognitive Function In First-episode Schizophrenia And Ultra High Risk Population
7.	A Comparative Study Of Cognitive Functions And Mental Status In Ultra High-risk For Psychosis
8.	A Comparative Study Of The Cognitive Function In Individuals At Ultra-high-risk For Schizophrenia
9.	Reseach Of Oxidative Stress And Cognitive Function In Schizophrenia Ultra High-risk Groups
10.	Control Study Of Cognitive Function Among Individuals At Ultra-High Risk Of Schizophrenia
11.	EMA-CO As Primary Treatment For Ultra High-Risk Gestational Trophoblastic Neoplasia
12.	Clinical Characteristics And Prognosis Of Ultra High-risk Gestational Trophoblastic Neoplasia
13.	A Comparative Study Of Short-term Low Density Lipoprotein Cholesterol (LDL)Attainment Rate In Ultra-high Risk Patients Undergoing Coronary Intervention Using Initial Drug Combination Versus A Single Drug Lipid-lowering Regimen
14.	Efficacy Evaluation Of Ultrasonography For Carotid Artery Plaque After Lipid-lowering Therapy In Ultra-high-risk ASCVD Patients
15.	Clinical Study Of LDL-C In Patients With Ultra-high Risk ASCVD Treated With Statins Combined With Non-statins
16.	The Mechanism Of Cognitive Impairment And The Development Of Multi-dimensional Identification Model Of College Students At Ultra-high Risk For Psychosis
17.	A Clinical Study Of The Effect Of PCSK9 Inhibitor In Ultra-high Risk ASCVD With Percutaneous Coronary Intervention Patients
18.	Risk Factors For Ultra-high-risk ASCVD In-stent Restenosis In Coronary Arteries
19.	Effect Of Early Use Of Envolocumab On Cardiovascular Adverse Events In Patients With Ultra-high Risk Atherosclerotic Cardiovascular Disease After Percutaneouscoronary Intervention
20.	The Observation Of The Early Efficacy Of PCSK9 Inhibitors-Evolocumab In Ultra-high-risk ACS Patients
<<First <Prev Next> Last>> Jump to